These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1402141

  • 1. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH, Maezawa H, Urano M.
    Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141
    [Abstract] [Full Text] [Related]

  • 2. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M, Wong KH, Reynolds R, Begley J.
    Int J Hyperthermia; 1995; 11(3):379-88. PubMed ID: 7636324
    [Abstract] [Full Text] [Related]

  • 3. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
    [Abstract] [Full Text] [Related]

  • 4. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 5. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [Abstract] [Full Text] [Related]

  • 6. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J.
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [Abstract] [Full Text] [Related]

  • 7. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH, Urano M.
    Int J Radiat Oncol Biol Phys; 1992 Mar; 23(3):593-8. PubMed ID: 1612960
    [Abstract] [Full Text] [Related]

  • 9. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS.
    Int J Hyperthermia; 1991 Mar; 7(5):773-84. PubMed ID: 1834752
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
    Mulcahy RT, Gipp JJ, Tanner MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):57-65. PubMed ID: 3496311
    [Abstract] [Full Text] [Related]

  • 11. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW, Hill SA.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles.
    Fujimoto S, Ohta M, Shrestha RD, Kokubun M, Miyoshi T, Mori T, Arimizu N, Okui K.
    Br J Cancer; 1988 Jul; 58(1):42-5. PubMed ID: 3166892
    [Abstract] [Full Text] [Related]

  • 13. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J, Hirst DG, Stewart FA, Terry NH.
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [Abstract] [Full Text] [Related]

  • 14. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P, Twentyman PR.
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [Abstract] [Full Text] [Related]

  • 15. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC.
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [Abstract] [Full Text] [Related]

  • 16. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 17. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A, Stewart FA, Denekamp J.
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA, Teicher BA, Herman TS.
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [Abstract] [Full Text] [Related]

  • 20. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW, Alliet KL.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.